Natera options flow shows 12.6:1 put/call ratio near 52-week high
Natera Inc (NTRA) options show a 12.6:1 put/call ratio, with 2,934 puts vs. 233 calls, near its 52-week high of $415.75. The largest put strikes are $400, $360, and $320, with low open interest suggesting new positions. Insiders sold shares in 2024, adding to the bearish sentiment.
How this was made
The 30-second read
Why it matters
The surge in put volume may attract short sellers or prompt defensive positioning by existing holders.
Market read
Options flow indicates potential short‑term volatility for NTRA, relevant for traders monitoring biotech equities.
What to watch
Recent insider sales and prior bullish call activity may temper the bearish interpretation.
Background
Natera is a genetic testing company whose stock has rallied sharply over the past year.
Ticker impact
Options flow shows a 12.6:1 put/call ratio on Natera, indicating heavy bearish positioning despite the stock near its 52‑week high.
Short‑term downside pressure; possible 3‑5% dip if bearish bets materialize.
Fresh opening put positions at strikes close to the market price signal a speculative bet on a modest decline.
Market effects
High options activity may signal broader caution in the biotech/diagnostics sector.
Primarily U.S. market; limited regional spillover.
Minimal global impact beyond sector sentiment.
Counterpoint
The put buying could be pure portfolio insurance, not a bearish bet, implying limited downside risk.
Key entities
- companyNatera Inc.
Genetic testing and diagnostics firm.
